CMMB - Chemomab Therapeutics Ltd DRC - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Chemomab Therapeutics Ltd DRC's activity chart (see below) currently has 7 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 106.86 days.

Most recent stock forecast was given by JEFF JONES from OPPENHEIMER on 27-Aug-2025. First documented stock forecast 11-Mar-2019.

Best performing analysts who are covering CMMB - Chemomab Therapeutics Ltd DRC:

Jeff Jones Nathan Weinstein James Edwardes Jones Leland Gershell Michael Okunewitch Kristen Kluska

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Jul-2024

$25

$22.29 (822.51%)

$10

Buy Since 13-May-2024

$28

$26.22 (1473.03%)

$16

Show more analysts

Please expand the browser size to see the chart

What is CMMB (Chemomab Therapeutics Ltd DRC) average time for price targets to be met?

On average it took 106.86 days on average for the stock forecasts to be realized with a an average price target met ratio 32.86

Which analyst has the current highest performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?

Which analyst has the current lower performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on CMMB (Chemomab Therapeutics Ltd DRC)?

has 0 price targets and 0 ratings on CMMB

Which analyst is the currently most bullish on CMMB (Chemomab Therapeutics Ltd DRC)?

Kristen Kluska with highest potential upside - $43.33

Which analyst is the currently most reserved on CMMB (Chemomab Therapeutics Ltd DRC)?

Nathan Weinstein with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?